Companies: 10,795·Total market cap: $144.5T

Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy

FPHAFOTCHealthcare

$3.30

+$0.00(+0.00%)

Market Cap$209542410

P/E Ratio—

52W High$3.3

52W Low$3.3

Avg Volume0

Open$3.30

Beta0.18

Net Income Financials Revenue

Faron Pharmaceuticals Oy (FPHAF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

FPHAF · net income · updated Jun 9, 2026

Core profitability metrics

FPHAF · net income · margin · TTM · CAGR

Net income was −$25,920 for FY2024 (fiscal year ending 2024-12-31), up 99.9% year-over-year. Net profit margin was —.

FY2024 Net Income−$25,920▲ +99.9% YoY

Trailing 12M (TTM)−$31.0Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change+99.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · FPHAF net income history · FPHAF profit margin

Annual net income data

FPHAF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2024Loss−$25,920▲ +99.9%—$0

FY2023Loss−$30.9M▼ 3.0%—$0

FY2022Loss−$30.0M▼ 41.7%—$0

FY2021Loss−$21.2M▼ 25.1%—$0

FY2020Loss−$16.9M▼ 27.8%—$0

Net income vs peers (Healthcare)

FPHAF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Faron Pharmaceuticals OyYOU

FPHAF

−$25,920+99.9%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Faron Pharmaceuticals Oy (FPHAF) reported net income of −$25,920 for FY2024 (fiscal year ending 2024-12-31), up 99.9% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Faron Pharmaceuticals Oy has not yet achieved annual profitability based on available data (13 fiscal years). The company has reported net losses across all available periods.

Faron Pharmaceuticals Oy's net profit margin was — for FY2024, based on the latest annual results.

Investors sometimes search for "Faron Pharmaceuticals Oy net worth" — the company's market capitalization is a separate figure from FPHAF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

FPHAF net income · 4 questions

Faron Pharmaceuticals Oy is not currently profitable on an annual basis. The company reported a net loss of $25,920 for FY2024.

is FPHAF profitabledoes FPHAF make a profitFPHAF profitabilityFPHAF profitable company

▸ Source: FMP /income-statement · GAAP · Faron Pharmaceuticals Oy · Faron Pharmaceuticals Oy SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026